| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |